Therapeutic suppression of pulmonary neutrophilia and allergic airway hyperresponsiveness by an RORγt inverse agonist

Airway neutrophilia occurs in approximately 50% of patients with asthma and is associated with particularly severe disease. Unfortunately, this form of asthma is usually refractory to corticosteroid treatment, and there is an unmet need for new therapies. Pulmonary neutrophilic inflammation is assoc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Autores principales: Whitehead, Gregory S., Kang, Hong Soon, Thomas, Seddon Y., Medvedev, Alexander, Karcz, Tadeusz P., Izumi, Gentaro, Nakano, Keiko, Makarov, Sergei S., Nakano, Hideki, Jetten, Anton M., Cook, Donald N.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Clinical Investigation 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6675583/
https://ncbi.nlm.nih.gov/pubmed/31184998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.125528
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares